Frank F. Craig
Chairman
Board of Director
Vivantis Technologies Sdn. Bhd.
Malaysia
Biography
Dr Craig has around 15 years of international, general management experience gained from GlaxoSmithKline, Amersham Biosciences (as a Vice-President of R&D) and several start-up firms. He was responsible for managing product development of Green Fluorescent Protein (first identified by the 2008 Nobel Prize Winners for Chemistry) and many other products and services for the Life Sciences industry. Frank is a (co)-Founder of Aurora Biosciences (San Diego, USA), which had a peak market cap. of £1.6 billion. He was also a co-Founder and CEO of Smart Holograms (Cambridge, UK) - named as the UK's Fastest Growing Company. Frank has raised £16 million in Venture Capital, £23 million via an IPO on NASDAQ and has delivered many commercial partnerships with global Life Sciences and Energy firms - resulting in recorded deal values of £180 million. He has been a Board Director of Smart Holograms and TekCel (Hopkinton, USA). Frank is currently the CEO of Sphere Fluidics, commercialising new lab-on-a-chip and picodroplet technology from Cambridge University. He has a PhD in Cell Biology and Microbiology from Glasgow University and an MBA from Warwick Business School.
Research Interest
Cell Biology, Molecular Biology, Microbiology
